Fate Therapeutics Inc. sell Bank of America Co.
Start price
28.03.24
/
50%
€6.80
Target price
28.03.25
€5.56
Performance (%)
-49.96%
Price
07.06.24
€3.40
Summary
This prediction is currently active. The SELL prediction by Bank_of_America_Co_ for Fate Therapeutics Inc. is performing very well with a performance of -49.96%. This prediction currently runs until 28.03.25. The prediction end date can be changed by Bank_of_America_Co_ at any time. Bank_of_America_Co_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Fate Therapeutics Inc. | -0.059% | -0.059% |
iShares Core DAX® | -0.258% | 0.299% |
iShares Nasdaq 100 | 2.964% | 4.660% |
iShares Nikkei 225® | 1.217% | -2.160% |
iShares S&P 500 | 1.732% | 2.807% |
Comments by Bank_of_America_Co_ for this prediction
In the thread Fate Therapeutics Inc. diskutieren
Fate Therapeutics, Inc. (NASDAQ: FATE) had its price target raised by analysts at Bank of America Co. from $2.00 to $6.00. They now have an "underperform" rating on the stock.
Ratings data for FATE provided by MarketBeat